MediPharm Labs Corp.

OTCPK:MEDI.F Stock Report

Market Cap: US$23.7m

MediPharm Labs Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

David Pidduck

Chief executive officer

CA$3.6m

Total compensation

CEO salary percentage8.6%
CEO tenure2yrs
CEO ownership3.3%
Management average tenure3.9yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Pidduck's remuneration changed compared to MediPharm Labs's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CA$13m

Sep 30 2023n/an/a

-CA$16m

Jun 30 2023n/an/a

-CA$19m

Mar 31 2023n/an/a

-CA$26m

Dec 31 2022CA$4mCA$315k

-CA$30m

Compensation vs Market: David's total compensation ($USD2.67M) is above average for companies of similar size in the US market ($USD670.12K).

Compensation vs Earnings: Insufficient data to compare David's compensation with company performance.

CEO

David Pidduck

2yrs

Tenure

CA$3,641,903

Compensation

Mr. David A. Pidduck is Chief Executive Officer and President of MediPharm Labs Corp. since April 20, 2022. Mr. Pidduck has been the Chief Executive Officer and President of Purdue Pharma Inc. since Septem...

Leadership Team

NamePositionTenureCompensationOwnership
David Pidduck
CEO & Director2yrsCA$3.64m3.3%
CA$ 781.5k
Keith Strachan
Co-Founder & President5.2yrsCA$1.07m0.51%
CA$ 120.1k
Greg Hunter
Chief Financial Officer3.2yrsCA$1.20m0.21%
CA$ 49.9k
Patrick McCutcheon
Founder9.3yrsCA$858.16kno data
Saravan Subramaniam
Vice President of Operations & Supply Chain3.3yrsno datano data
Geoffrey Marr
Executive VP & General Counselno datano datano data
Brett Moon
Vice President of Sales3.9yrsno datano data
Kirk Binns
Executive Vice President of Global Accounts5.2yrsno datano data

3.9yrs

Average Tenure

Experienced Management: MEDI.F's management team is considered experienced (3.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
David Pidduck
CEO & Director2yrsCA$3.64m3.3%
CA$ 781.5k
Shelley Martin
Independent Director3.8yrsCA$51.30kno data
Michael Bumby
Independent Directorless than a yearno data0.029%
CA$ 6.8k
Christopher Taves
Independent Chairman of the Board3.8yrsCA$40.50k0.25%
CA$ 58.6k
Miriam McDonald
Member of the Science Advisory Board5yrsCA$40.50k0%
CA$ 0
Leslie Brown
Member of the Science Advisory Board5yrsno datano data
Matt Archibald
Member of the Science Advisory Board5yrsno datano data
Markus Roggen
Member of the Science Advisory Board5yrsno datano data
Arshad Hack
Member of the Science Advisory Board5yrsno datano data
Jerry King
Member of the Science Advisory Board5yrsno datano data
Carolina Landolt-Marticorena
Member of the Science Advisory Board4.7yrsno datano data
Christopher Halyk
Independent Director3.7yrsCA$40.50k0.021%
CA$ 5.0k

4.8yrs

Average Tenure

Experienced Board: MEDI.F's board of directors are considered experienced (4.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.